News
05.07.2021
PMA Insights: Week 27

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
05.07.2021
NICE HST program provide faster market access

The HST process is a method for evaluating medicines and treatments specifically indicated for ultra...

Read more
Articles
30.06.2021
Clinical trial design for HTA

Clinical evidence relating to therapeutic efficacy and safety is one of the most valuable criteria o...

Read more
Articles
28.06.2021
COVID-19 pandemic shaping industry

One year after the first lockdown was announced in the UK we take a brief look at trends and changes...

Read more
Articles
25.06.2021
EU Joint HTA Process Finally Agreed

The European Parliament and Council negotiators reached a provisional agreement on a joint health te...

Read more
Articles
21.06.2021
UK the next hub for Biosimilars

Biosimilars could be launching a lot earlier in the UK than the EU thanks to new guidance, improved ...

Read more
Articles
16.06.2021
Early market access in France is changing

France's new Social Security Financing Bill (SSFB) will be coming into place no later than July 1st.

Read more
Articles
02.06.2021
EU Joint HTA EESC publish its positive option

Are we one step closer to an EU Health Technology Assessment body. The EESC publish its positive opi...

Read more
Articles
26.05.2021
Better internal communications

4 ways to improve market access through communication

Read more
Articles
21.05.2021
Cross-functional collaboration

There is a large opportunity many companies are still yet to seize in this area.

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.